Annual CFI
-$50.00 K
-$58.00 K-725.00%
December 31, 2023
Summary
- As of February 12, 2025, NRBO annual cash flow from investing activities is -$50.00 thousand, with the most recent change of -$58.00 thousand (-725.00%) on December 31, 2023.
- During the last 3 years, NRBO annual CFI has fallen by -$119.00 thousand (-172.46%).
- NRBO annual CFI is now -172.46% below its all-time high of $69.00 thousand, reached on December 31, 2020.
Performance
NRBO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
+$3000.00+100.00%
September 30, 2024
Summary
- As of February 12, 2025, NRBO quarterly cash flow from investing activities is $0.00, with the most recent change of +$3000.00 (+100.00%) on September 30, 2024.
- Over the past year, NRBO quarterly CFI has increased by +$9000.00 (+100.00%).
- NRBO quarterly CFI is now -100.00% below its all-time high of $71.00 thousand, reached on December 31, 2020.
Performance
NRBO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$17.00 K
+$37.00 K+68.52%
September 30, 2024
Summary
- As of February 12, 2025, NRBO TTM cash flow from investing activities is -$17.00 thousand, with the most recent change of +$37.00 thousand (+68.52%) on September 30, 2024.
- Over the past year, NRBO TTM CFI has increased by +$33.00 thousand (+66.00%).
- NRBO TTM CFI is now -123.94% below its all-time high of $71.00 thousand, reached on March 31, 2021.
Performance
NRBO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
NRBO Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -725.0% | +100.0% | +66.0% |
| 3 y3 years | -172.5% | 0.0% | -125.0% |
| 5 y5 years | -1566.7% | +100.0% | +99.7% |
NRBO Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -725.0% | +91.5% | -100.0% | +100.0% | -312.5% | +97.1% |
| 5 y | 5-year | -172.5% | +99.2% | -100.0% | +100.0% | -123.9% | +99.7% |
| alltime | all time | -172.5% | +99.2% | -100.0% | +100.0% | -123.9% | +99.7% |
NeuroBo Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | -$17.00 K(-68.5%) |
| Jun 2024 | - | -$3000.00(-40.0%) | -$54.00 K(+5.9%) |
| Mar 2024 | - | -$5000.00(-44.4%) | -$51.00 K(+2.0%) |
| Dec 2023 | -$50.00 K(-725.0%) | -$9000.00(-75.7%) | -$50.00 K(+22.0%) |
| Sep 2023 | - | -$37.00 K(<-9900.0%) | -$41.00 K(+925.0%) |
| Jun 2023 | - | $0.00(-100.0%) | -$4000.00(-200.0%) |
| Mar 2023 | - | -$4000.00(<-9900.0%) | $4000.00(-50.0%) |
| Dec 2022 | $8000.00(-101.4%) | $0.00(0.0%) | $8000.00(-101.4%) |
| Sep 2022 | - | $0.00(-100.0%) | -$575.00 K(0.0%) |
| Jun 2022 | - | $8000.00(>+9900.0%) | -$575.00 K(-1.9%) |
| Mar 2022 | - | $0.00(-100.0%) | -$586.00 K(0.0%) |
| Dec 2021 | -$586.00 K(-949.3%) | -$583.00 K(<-9900.0%) | -$586.00 K(-961.8%) |
| Sep 2021 | - | $0.00(-100.0%) | $68.00 K(0.0%) |
| Jun 2021 | - | -$3000.00(<-9900.0%) | $68.00 K(-4.2%) |
| Mar 2021 | - | $0.00(-100.0%) | $71.00 K(+2.9%) |
| Dec 2020 | $69.00 K | $71.00 K(>+9900.0%) | $69.00 K(-101.2%) |
| Sep 2020 | - | $0.00(0.0%) | -$5.94 M(-1.5%) |
| Jun 2020 | - | $0.00(-100.0%) | -$6.03 M(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$2000.00(-100.0%) | -$6.06 M(+0.0%) |
| Dec 2019 | -$6.06 M(>+9900.0%) | -$5.94 M(+6286.0%) | -$6.06 M(+4905.8%) |
| Sep 2019 | - | -$93.00 K(+272.0%) | -$121.00 K(+332.1%) |
| Jun 2019 | - | -$25.00 K(<-9900.0%) | -$28.00 K(+833.3%) |
| Mar 2019 | - | $0.00(-100.0%) | -$3000.00(0.0%) |
| Dec 2018 | -$3000.00(<-9900.0%) | -$3000.00(<-9900.0%) | -$3000.00(<-9900.0%) |
| Sep 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | - | - |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2015 | - | $0.00 | $0.00 |
| Dec 2014 | $0.00 | - | - |
FAQ
- What is NeuroBo Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals annual CFI year-on-year change?
- What is NeuroBo Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly CFI year-on-year change?
- What is NeuroBo Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals TTM CFI year-on-year change?
What is NeuroBo Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of NRBO is -$50.00 K
What is the all time high annual CFI for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high annual cash flow from investing activities is $69.00 K
What is NeuroBo Pharmaceuticals annual CFI year-on-year change?
Over the past year, NRBO annual cash flow from investing activities has changed by -$58.00 K (-725.00%)
What is NeuroBo Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of NRBO is $0.00
What is the all time high quarterly CFI for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high quarterly cash flow from investing activities is $71.00 K
What is NeuroBo Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, NRBO quarterly cash flow from investing activities has changed by +$9000.00 (+100.00%)
What is NeuroBo Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of NRBO is -$17.00 K
What is the all time high TTM CFI for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high TTM cash flow from investing activities is $71.00 K
What is NeuroBo Pharmaceuticals TTM CFI year-on-year change?
Over the past year, NRBO TTM cash flow from investing activities has changed by +$33.00 K (+66.00%)